Furthermore, since GHSR 1b is reported to be an inactive isoform of the receptor [35], loss of expression of GHSR 1a and overexpression of GHSR 1b may be functionally equivalent mechanisms of altering the ghrelin/GHSR axis in breast cancer. This evidence concerns the gene GHSR and breast cancer.